Related Experiment Video
Updated: Jul 26, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway
A Hayman1, S Comely, A Lackenby
1School of Biological Sciences, University of Reading, Whiteknights, Reading RG6 6AJ, UK.
Abstract:
We investigated the ability of a selection of human influenza A viruses, including recent clinical isolates, to induce IFN-beta production in cultured cell lines. In contrast to the well-characterized laboratory strain A/PR/8/34, several, but not all, recent isolates of H3N2 viruses resulted in moderate IFN-beta stimulation. Through the generation of recombinant viruses, we were able to show that this is not due to a loss of the ability of the NS1 genes to suppress IFN-beta induction; indeed, the NS1 genes behaved similarly with respect to their abilities to block dsRNA signaling. Interestingly, replication of A/Sydney/5/97 virus was less susceptible to pre-treatment with IFN-alpha than the other viruses. In contrast to the universal effect on dsRNA signaling, we noted differences in the effect of NS1 proteins on expression of interferon stimulated genes and also genes induced by a distinct pathway. The majority of NS1 proteins blocked expression from both IFN-dependent and TNF-dependent promoters by an apparent post-transcriptional mechanism. The NS1 gene of A/PR/8/34 NS1 did not confer these blocks. We noted striking differences in the cellular localization of different influenza A virus NS1 proteins during infection, which might explain differences in biological activity.
Insights
Recent influenza A virus isolates vary in their ability to stimulate interferon-beta (IFN-beta) production. Differences in the NS1 protein
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Influenza A viruses are a significant public health concern.
- Interferon-beta (IFN-beta) is a key cytokine in antiviral defense.
- The NS1 protein of influenza A virus is known to antagonize the host immune response.
Purpose of the Study:
- To investigate the capacity of recent human influenza A virus clinical isolates to induce IFN-beta production.
- To elucidate the role of the NS1 gene in modulating IFN-beta induction and interferon-stimulated gene expression.
- To explore differences in the biological activity of NS1 proteins from various influenza A virus strains.
Main Methods:
- Culturing of human influenza A viruses, including recent clinical isolates and recombinant viruses.
- Assessment of IFN-beta production in cultured cell lines.
- Analysis of NS1 protein function in blocking dsRNA signaling and regulating gene expression.
- Evaluation of viral replication susceptibility to IFN-alpha pre-treatment.
- Investigation of NS1 protein cellular localization during infection.
Main Results:
- Recent H3N2 influenza A virus isolates showed moderate IFN-beta stimulation, unlike the laboratory strain A/PR/8/34.
- NS1 genes from recent isolates retained the ability to suppress IFN-beta induction and block dsRNA signaling.
- Differences were observed in the NS1 proteins' effects on interferon-stimulated genes and TNF-dependent pathways, with most blocking expression post-transcriptionally, a function absent in A/PR/8/34 NS1.
- A/Sydney/5/97 virus exhibited reduced susceptibility to IFN-alpha pre-treatment.
- Significant variations in the cellular localization of NS1 proteins were noted among different influenza A virus strains.
Conclusions:
- Recent influenza A virus clinical isolates exhibit varied abilities to induce IFN-beta production.
- The NS1 protein plays a crucial role in modulating host antiviral responses, with strain-specific differences in its function and localization.
- Understanding these NS1-mediated immune evasion mechanisms is vital for developing effective antiviral strategies against influenza A.
More Related Videos
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Related Concept Videos
Leaky Scanning
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Influenza
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release